Church & Dwight (CHD) has been actively engaging in significant acquisitions and stock-related activities. The company has recalls over microbial contamination concerns for Zicam and Orajel products. Several major stock sales and purchases have occurred, including those by Carlen Hooker and Ravichandra Krishnamu Saligram. Truist Securities and RBC Capital have both raised their price target for CHD. The company has significantly boosted the brand's product line by acquiring the Touchland brand for $700M and $880M. Opinions from brokerages have currently settled CHD at a 'hold' rating. Q1 earnings are positive, leading the way and surpassing estimates, although lower organic sales have had an impact. M&A with Touchland Inc. has been announced. Voluntary recalls, specifically of Zicam, and a cut growth and profit outlook amidst slow growth are among the recent challenges faced by the company. Currently, billionaire investors suggest CHD as one of the potential oversold stocks to buy, reflecting uncertainty in market valuation. These developments and actions indicate an active and alert presence in the market stage by CHD.
Church Dwight CHD News Analytics from Fri, 01 Nov 2024 07:00:00 GMT to Sat, 07 Jun 2025 17:15:47 GMT -
Rating 3
- Innovation -4
- Information 5
- Rumor 4
